4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: April 13, 2020
Period of Report: April 7, 2020
Accession Number: 0001104659-20-045926

View Document ↗ View on SEC.gov ↗